Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 42,052.0 | $1.0M | 0.14% | NEW | — | $24.81 | +37.1% |
| 62 | — | RADIOPHARM THERANOSTICS LTD | — | 187,406.0 | $978K | 0.14% | — | — | $5.22 | — |
| 63 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 100,000.0 | $750K | 0.10% | NEW | — | $7.50 | +30.8% |
| 64 | ADGM | ADAGIO MED HLDGS INC | Healthcare | 515,384.0 | $536K | 0.07% | NEW | — | $1.04 | -17.3% |
| 65 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 9,659.0 | $293K | 0.04% | -194K | -95.3% | $30.34 | +25.1% |
| 66 | — | PALISADE BIO INC | — | 102,108.0 | $240K | 0.03% | NEW | — | $2.35 | — |
| 67 | — | IBIO INC | — | 106,000.0 | $205K | 0.03% | NEW | — | $1.93 | — |
| 68 | — | ROCKET PHARMACEUTICALS INC | — | 104,828.0 | $3K | — | — | — | $0.02 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%